HADJISTILIANOU THEODORA

Teaching activities

Completion accademic year: 2024/2025

Course year: 3 First cycle degree (DM 270) ORTHOPTIC AND OPHTALMOLOGIC ASSISTANCE A.Y. 2022/2023

Completion accademic year: 2023/2024

Course year: 3 First cycle degree (DM 270) ORTHOPTIC AND OPHTALMOLOGIC ASSISTANCE A.Y. 2021/2022

Completion accademic year: 2022/2023

Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2019/2020
Course year: 2 OFTALMOLOGIA A.Y. 2021/2022
Course year: 2 OFTALMOLOGIA A.Y. 2021/2022
Course year: 2 OFTALMOLOGIA A.Y. 2021/2022
Course year: 1 OFTALMOLOGIA A.Y. 2022/2023
Course year: 3 First cycle degree (DM 270) ORTHOPTIC AND OPHTALMOLOGIC ASSISTANCE A.Y. 2020/2021

Completion accademic year: 2021/2022

Research

Ultime pubblicazioni:

  • Rubegni, G., Zeppieri, M., Russo, A., Castellino, N., Fruschelli, M., Hadjistilianou, T., et al. (2024). Comparing New Smartphone-Connected Handheld Ultrasound Device vs. Traditional Ultrasound in Vitreo-Retinal Disease Diagnosis. DIAGNOSTICS, 14(17) [10.3390/diagnostics14171961]. - view more
  • Hadjistilianou, T., Menicacci, C., Luciani, D., Dalessandro, C., DE FRANCESCO, S., Bacci, T., et al. (2023). Retinal VasoProliferative Tumors (RVPT) in Neurofibromatosis Type 1. In 23rd Euretina Congress. Basel : European Society of Retina Specialists. - view more
  • Hadjistilianou, T., Bracco, S., Barchitta, M., Bertelli, E. (2023). Intra-arterial Chemotherapy for Retinoblastoma: A Team Effort. In Global Perspectives in Ocular Oncology (pp. 45-61). Berlin : Springer [10.1007/978-3-031-08250-4_7]. - view more
  • Menicacci, C., Al-Jamal, R.T., De Francesco, S., Barchitta, M., Girolamo, M., Di Maggio, A., et al. (2022). Very late orbital recurrence of choroidal melanoma four decades post enucleation. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 32(4), NP88-NP93 [10.1177/11206721211001266]. - view more
  • The Global Retinoblastoma Study, G., Fabian, I.D., Abdallah, E., Abdullahi, S.U., Abdulqader, R.A., Abdulrahaman, A.A., et al. (2022). The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries. THE LANCET GLOBAL HEALTH, 10(8), e1128-e1140 [10.1016/S2214-109X(22)00250-9]. - view more